Excellere Partners, a Denver-based private equity firm specialising in partnering with entrepreneurs and management teams through recapitalisations and management buyouts, has hired Michael Geldart as Partner.
David Kessenich, Managing Partner and Co-Founder of Excellere Partners, says: “We are excited to welcome Michael to Excellere Partners. He is a strategic-minded, results-oriented leader with an entrepreneurial mindset. With his vast healthcare experience in legal, regulatory compliance and operations, Michael will be an extremely value-added team member to our current and future healthcare investments.”
Geldart has more than 20 years of experience in executive leadership, health law, and corporate development. Most recently, Michael was the Chief Operating Officer of BioTelemetry (Nasdaq:BEAT), the leading provider of cardiac monitoring, cardiac monitoring device manufacturing, and centralised cardiac core laboratory services. Prior to joining BioTelemetry in 2012, Geldert was the Chief Operating Officer of MedExpress (a former portfolio company of Excellere Partners), a leading multi-state Urgent Care provider. Prior to joining MedExpress, Michael was the Chief Operating Officer and EVP of Corporate Development of CCS Medical, a national provider of Medical and Pharmacy supplies for patients suffering from diabetes, respiratory and other chronic conditions. Prior to CCS Medical, Geldert was a partner at Holland & Knight, LLP, a global law firm, serving as the Co-Chair of the firm’s National Health Care Practice Group. Michael received a Bachelor of Arts in Chemistry from the University of South Florida, and Juris Doctor degree from Stetson University College of Law. Michael is a member of the Florida Bar.
